🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
23.16
-0.43 (-1.82%)
At close: Nov 20, 2026, 4:00 PM EST
23.16
0.00 (0.00%)
After-hours: Nov 20, 2026, 7:30 PM EST

Rapport Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-150.47-111.48-78.31-34.79-11.62
Depreciation & Amortization
0.91.020.840.110.02
Asset Writedown & Restructuring Costs
----5.45
Loss (Gain) From Sale of Investments
-1.44-1.4-3.21-0.08-
Stock-Based Compensation
27.4918.8610.243.530.61
Other Operating Activities
2.362.038.031.390.38
Change in Accounts Payable
-1.292.22-0.350.861.58
Change in Other Net Operating Assets
1.631.29-2.071.80.05
Operating Cash Flow
-120.85-87.47-64.83-27.18-3.54
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-0.33-0.62-2.41-1.64-0.31
Sale (Purchase) of Intangibles
-----5.45
Investment in Securities
-59.79-186.86-167.74-77.22-
Investing Cash Flow
-59.72-187.47-170.14-78.86-5.76

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt Issued
----8.73
Net Debt Issued (Repaid)
----8.73
Issuance of Common Stock
4.42270.79157.710.050.03
Repurchase of Common Stock
-0.01-0--0-
Other Financing Activities
-0.45---0.13-0.11
Financing Cash Flow
3.96270.79221.63145.1443.29

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
-176.61-4.16-13.3439.133.99

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-121.18-88.09-67.23-28.82-3.85
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-2.56-2.26-3.24-19.14-4.95
Levered Free Cash Flow
-75.28-54.17-44.47-17.43-
Unlevered Free Cash Flow
-75.28-54.17-44.47-17.43-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
0.183.5-2.422.651.62
SEC Filings: 10-K · 10-Q